OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.53
-0.05 (-3.16%)
As of Mar 29, 10:45 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,788.2% upside
Low Target $16.92
Average Target $28.89
High Target $30.86
Current Price $1.53
Current
$1.53
Target
$28.89
$16.92 $28.89 avg $30.86
Scenario Analysis
Bear Case
$16.92
1,005.9%
Low target
Base Case
$28.89
+1,788.2%
Avg target
Bull Case
$30.86
+1,917.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.35
-54.3% from high
52-Week Low
$1.03
+48.5% from low
Target vs 52W High
$28.89
+762.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%